Tower Research Capital LLC (TRC) - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 54 filers reported holding SPERO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$692
+1256.9%
572
+1534.3%
0.00%
Q2 2023$51
+5000.0%
35
-93.5%
0.00%
Q1 2023$1
-98.2%
541
-98.4%
0.00%
-100.0%
Q4 2022$57
-99.8%
33,164
+81.8%
0.00%
+100.0%
Q3 2022$37,000
+94.7%
18,239
-27.3%
0.00%
Q2 2022$19,000
-82.4%
25,077
+101.9%
0.00%
-100.0%
Q1 2022$108,000
-23.4%
12,423
+41.7%
0.00%
-50.0%
Q4 2021$141,000
+642.1%
8,768
+770.7%
0.00%
Q3 2021$19,000
-83.8%
1,007
-88.0%
0.00%
-100.0%
Q2 2021$117,000
+154.3%
8,384
+166.5%
0.00%
+200.0%
Q1 2021$46,000
+109.1%
3,146
+171.2%
0.00%0.0%
Q4 2020$22,000
-87.5%
1,160
-92.7%
0.00%
-50.0%
Q3 2020$176,000
+375.7%
15,784
+475.8%
0.00%0.0%
Q2 2020$37,000
+1750.0%
2,741
+1129.1%
0.00%
Q3 2019$2,000
-75.0%
223
-68.9%
0.00%
-100.0%
Q2 2019$8,000
+14.3%
718
-35.9%
0.00%0.0%
Q4 2018$7,0001,120
+2847.4%
0.00%
Q3 2018$0
-100.0%
38
-72.3%
0.00%
Q2 2018$2,000
-91.7%
137
-93.4%
0.00%
-100.0%
Q4 2017$24,0002,0890.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders